Dr. Barkan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1500 East Medical Center Dr
2nd Floor Taubman Ctr Recp G
Ann Arbor, MI 48109Phone+1 734-936-5020Fax+1 734-936-9294
Education & Training
University of MichiganFellowship, Endocrinology, Diabetes, and Metabolism, 1980 - 1983
Minsk Medical InstituteClass of 1972
Certifications & Licensure
MI State Medical License 1983 - 2026- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
- Elected Member The American Society for Clinical Investigation, 1993
Clinical Trials
- Efficacy and Safety of Pasireotide Administered Monthly in Patients With Cushing's Disease Start of enrollment: 2011 Nov 04
- Study to Allow Access to Pasireotide for Patients Benefiting From Pasireotide Treatment in Novartis-sponsored Studies Start of enrollment: 2013 Jun 10
Publications & Presentations
PubMed
- 4 citationsBiochemical efficacy of long-acting lanreotide depot/Autogel in patients with acromegaly naïve to somatostatin-receptor ligands: analysis of three multicenter clinical...Hussain Alquraini, Maria del Pilar Schneider, Beloo Mirakhur, Ariel L. Barkan
Pituitary. 2018-01-22 - 6 citationsDecreased quality of life (QoL) in hypopituitary patients: involvement of glucocorticoid replacement and radiation therapyAdnan Ajmal, Erin L. McKean, Stephen E. Sullivan, Ariel L. Barkan
Pituitary. 2018-10-22 - 128 citationsGlucose Homeostasis and Safety in Patients with Acromegaly Converted from Long-Acting Octreotide to PegvisomantAriel L. Barkan, Pia Burman, David R. Clemmons, William Drake, Robert F. Gagel
The Journal of Clinical Endocrinology and Metabolism. 2005-10-01
Press Mentions
Regents Roundup — June 2021June 17th, 2021- Human Growth Hormone Treatment After ACL Injury May Prevent Loss of Muscle StrengthMay 27th, 2020
Grant Support
- Training Program In Endocrinology And MetabolismNational Institute Of Diabetes And Digestive And Kidney Diseases2000–2010
- Defining Growth Hormone Deficiency In AdultsNational Center For Research Resources2006–2007
- Metabolic Adaptations Of Obesity With GH AdministrationNational Center For Research Resources2005–2006
- Blockade Of Growth Hormone W/Growth Hormone Releasing Hormone AntagonistNational Center For Research Resources2005–2006
- Pega-0435-005National Center For Research Resources2004–2006
- Efficacy/Safety Of Pegvisomant To That Of Sandostatin LAR Depot In AcromegalyNational Center For Research Resources2005
- Multi-Center, Open-Label Compassionate Use Program To Provide PegvisomantNational Center For Research Resources2004
- GH Pulsatility In AcromegalyNational Center For Research Resources2004
- Mechanisms Of Pulsatile Growth Hormone (GH) Secretion In HumansNational Center For Research Resources1999–2002
- Growth Hormone Releasing Hormone Antagonist Infusion In AcromegalicsNational Center For Research Resources1999–2002
- Effects Of Growth Hormone Releasing Hormone Antagonist (Ghrh-Ant) On GH ReleaseNational Center For Research Resources1997–2002
- Pulsatile Administration Of GHRH On Growth Hormone DynamicsNational Center For Research Resources1998–2000
- Training Program In Endocrinology And Metabolism.National Institute Of Diabetes And Digestive And Kidney Diseases1999
- Physiopathology Of Pulsatile GH Secretion In HumansNational Institute Of Diabetes And Digestive And Kidney Diseases1995–1998
- Physiopathology Of Pulsatile GH Secretion In HumansNational Institute Of Diabetes And Digestive And Kidney Diseases1987–1991
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
